+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

CRP2 (C/EBP beta) contains a bipartite regulatory domain that controls transcriptional activation, DNA binding and cell specificity



CRP2 (C/EBP beta) contains a bipartite regulatory domain that controls transcriptional activation, DNA binding and cell specificity



Embo Journal 14(13): 3170-3183



Two members of the C/EBP family of basic region-leucine zipper proteins enriched in the liver, C/EBP (C/EBP alpha) and CRP2 (C/EBP beta), were previously shown to transactivate the albumin promoter in a cell type-dependent manner. These proteins function efficiently in HepG2 hepatoma cells, but inefficiently in HeLa (epithelial) and L (fibroblastic) cells. Here we have investigated the mechanism for cell-specific control of CRP2 activity. We show that CRP2 contains a negative regulatory region composed of two elements, RD1 and RD2. Deletions of RD2 relieve the inhibition of CRP2 activity in L cells, but do not affect CRP2 function in HepG2 cells. These deletions also increase the DNA binding activity of CRP2 approximately 3-fold, suggesting that RD2-mediated repression of DNA binding activity is responsible for CRP2 inhibition in L cells. The adjacent RD1 element functions independently of RD2 and modulates the CRP2 activation domain, which we show to be composed of three subdomains that are conserved within the C/EBP protein family. RD1 does not affect cell type specificity, but inhibits the transactivation potential of GAL4-CRP2 hybrid proteins by 50-fold. These findings suggest that CRP2 assumes a tightly folded conformation in which the DNA binding and activation domains are masked by interactions with the regulatory domain and that to function efficiently in HepG2 cells the protein must undergo an activation step. We propose that relief of inhibition conferred by the regulatory domains also accounts for CRP2 activation in response to extracellular signals.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 042429185

Download citation: RISBibTeXText

PMID: 7621830


Related references

Crp2 (C/Ebp beta) contains a bipartite regulatory domain that controls transcriptional activation, Dna binding and cell specificity. The Embo Journal 14(13): 3170-3183, 1995

The DNA binding specificity of the bipartite POU domain and its subdomains. Embo Journal 11(13): 4993-5003, 1992

Transcriptional activation by CTF proteins is mediated by a bipartite low-proline domain. Proceedings of the National Academy of Sciences of the United States of America 91(9): 3901-3905, 1994

Identification of a transcriptional activation domain in yeast repressor activator protein 1 (Rap1) using an altered DNA-binding specificity variant. Journal of Biological Chemistry 292(14): 5705-5723, 2017

The DNA-binding domain of the Cys-3 regulatory protein of Neurospora crassa is bipartite. Biochemistry 31(12): 3197-3203, 1992

Functional mapping of MHC class II polymorphic residues. The alpha-chain controls the specificity for binding an Ad-versus an A k-restricted peptide and the beta-chain region 65-67 controls T cell recognition but not peptide binding. Journal of Immunology 146(9): 2952-2959, 1991

Characterization of the transcriptional regulator YY1. The bipartite transactivation domain is independent of interaction with the TATA box-binding protein, transcription factor IIB, TAFII55, or cAMP-responsive element-binding protein (CPB)-binding protein. Journal of Biological Chemistry 272(3): 1709-1717, 1997

Identification of a new binding motif for the paired domain of Pax-3 and unusual characteristics of spacing of bipartite recognition elements on binding and transcription activation. Journal of Biological Chemistry 273(30): 19153-9, 1998

Phosphorylation-induced dimerization of interferon regulatory factor 7 unmasks DNA binding and a bipartite transactivation domain. Molecular and Cellular Biology 20(23): 8803-8814, 2000

Transcriptional activation of the steroidogenic acute regulatory protein (StAR) gene: GATA-4 and CCAAT/enhancer-binding protein beta confer synergistic responsiveness in hormone-treated rat granulosa and HEK293 cell models. Molecular and Cellular Endocrinology 252(1-2): 92-101, 2006

The Amino Acid Specificity for Activation of Phenylalanine Hydroxylase Matches the Specificity for Stabilization of Regulatory Domain Dimers. Biochemistry 54(33): 5167-5174, 2015

Bipartite Nuclear Localization Signal Controls Nuclear Import and DNA-Binding Activity of IFN Regulatory Factor 3. Journal of Immunology 195(1): 289-297, 2015

A bipartite molecular module controls cell death activation in the Basal cell lineage of plant embryos. Plos Biology 11(9): E1001655, 2014

Active intracellular domain of Notch enhances transcriptional activation of CCAAT/enhancer binding protein beta on a rat pregnancy-specific glycoprotein gene. Biochemistry 39(7): 1675-1682, 2000

RNA target specificity of the STAR/GSG domain post-transcriptional regulatory protein GLD-1. Nature Structural & Molecular Biology 11(1): 20-28, 2004